O'Shaughnessy Asset Management’s Fortress Biotech FBIO Stock Holding History

O'Shaughnessy Asset Management’s Portfolio FBIO Stock Details FBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-127	Closed	-$6K	–	1642
2021 Q3	$6K	Hold	127	–	–	﹤0.01%	2278
2021 Q2	$7K	Hold	127	–	–	﹤0.01%	2071
2021 Q1	$7K	Hold	127	–	–	﹤0.01%	1849
2020 Q4	$6K	Hold	127	–	–	﹤0.01%	1630
2020 Q3	$8K	Hold	127	–	–	﹤0.01%	1400
2020 Q2	$5K	Buy	+127	New	+$4.72K	﹤0.01%	1369
2020 Q1	–	Sell	-323	Closed	-$12K	–	1445
2019 Q4	$12K	Buy	+323	New	+$8.29K	﹤0.01%	1254

Other funds holding FBIO

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SAM

Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

CPWM LLC Seattle, Washington $1.06B AUM 14.49% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

O'Shaughnessy Asset Management's FBIO Position: Q4 2021 in Review

O'Shaughnessy Asset Management sold out of Fortress Biotech (FBIO) in Q4 2021, closing a stake of 127 shares — an estimated $6K sold.

O'Shaughnessy Asset Management first reported a position in FBIO in Q4 2019 and held it in 7 quarters. The position peaked at $12K in Q4 2019. 82 funds tracked by Wall St. Rank hold FBIO as of Q4 2021.

O'Shaughnessy Asset Management reported no remaining Fortress Biotech position as of Q4 2021 after selling out during the quarter.
O'Shaughnessy Asset Management sold 127 Fortress Biotech shares in Q4 2021, an estimated $6K.
O'Shaughnessy Asset Management first reported a position in Fortress Biotech in Q4 2019 and held it in 7 quarters.
O'Shaughnessy Asset Management's Fortress Biotech position peaked at $12K in Q4 2019.
82 funds tracked by Wall St. Rank held Fortress Biotech as of Q4 2021.

Based on O'Shaughnessy Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.